KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 71 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $250,000 | -34.2% | 17,236 | -55.4% | 0.03% | -42.1% |
| Q2 2022 | $380,000 | +9.8% | 38,650 | +64.5% | 0.06% | +23.9% |
| Q1 2022 | $346,000 | +127.6% | 23,502 | +104.4% | 0.05% | +142.1% |
| Q4 2021 | $152,000 | -64.7% | 11,499 | -49.3% | 0.02% | -72.9% |
| Q4 2020 | $430,000 | +34.0% | 22,664 | -11.0% | 0.07% | +29.6% |
| Q3 2020 | $321,000 | +150.8% | 25,466 | +51.7% | 0.05% | +68.8% |
| Q1 2020 | $128,000 | -57.3% | 16,786 | -0.3% | 0.03% | -8.6% |
| Q4 2019 | $300,000 | +150.0% | 16,836 | +63.1% | 0.04% | +118.8% |
| Q3 2019 | $120,000 | -43.1% | 10,321 | +40.0% | 0.02% | -23.8% |
| Q1 2019 | $211,000 | – | 7,371 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |